Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

OCUL Ocular Therapeutix Inc

8.63

0.18 (2.13%)

Dec 21 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/25/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Pravin Dugel

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Ocular Therapeutix Charts.

Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Ocular Therapeutix Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

Ocular Therapeutix Inc News

More Ocular Therapeutix Inc News Articles

Intergrated Cannabis Sol... (PK)

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Digital Brand Media and ... (PK)

Lightwave Logic

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Fannie Mae (QB)

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions